Concerns Mount as TrumpRx Falls Short One Month In

TrumpRx, launched with high expectations, is facing scrutiny after just a month, highlighting gaps between promises and performance. Lilly's targeting of employers indicates a strategic move in the pharmaceutical landscape. Watch for regulatory updates and industry reactions that could shape the platform's future.